Lv1
56 积分 2022-06-10 加入
Solamargine improves the therapeutic efficacy of anti-PD-L1 in lung adenocarcinoma by inhibiting STAT1 activation
2个月前
已完结
Targeting KRAS in colorectal cancer immunotherapy: rationale, challenges and future directions
2个月前
已完结
Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer
2个月前
已完结
Discovery of novel 8-hydroxyquinoline derivatives as NLRP3 inflammasome inhibitors with therapeutic potential for inflammatory bowel disease
3个月前
已完结
IgA nephropathy
5个月前
已完结
IgA nephropathy
5个月前
已完结
ALIGNing the treatment of IgA nephropathy: Reducing proteinuria with endothelin A receptor inhibition
5个月前
已完结
Atrasentan: First Approval
5个月前
已完结
Endothelin receptor antagonists in chronic kidney disease
5个月前
已完结
Endothelin receptor antagonists in chronic kidney disease
5个月前
已完结
皖公网安备34019202002308
